These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8722313)

  • 21. Evolution of multi-drug resistant hepatitis B virus during sequential therapy.
    Yim HJ; Hussain M; Liu Y; Wong SN; Fung SK; Lok AS
    Hepatology; 2006 Sep; 44(3):703-12. PubMed ID: 16941700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular analysis of an HBsAg-negative hepatitis B virus mutant selected in a tenofovir-treated HIV-hepatitis B virus co-infected patient.
    Amini-Bavil-Olyaee S; Sheldon J; Lutz T; Trautwein C; Tacke F
    AIDS; 2009 Jan; 23(2):268-72. PubMed ID: 19098499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Major causes of antiviral drug resistance and implications for treatment of hepatitis B virus monoinfection and coinfection with HIV.
    Locarnini S; Warner N
    Antivir Ther; 2007; 12 Suppl 3():H15-23. PubMed ID: 18284179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation.
    Terrault NA; Carter JT; Carlson L; Roland ME; Stock PG
    Liver Transpl; 2006 May; 12(5):801-7. PubMed ID: 16628690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occult hepatitis B infection in patients infected with HIV: report of two cases of hepatitis B reactivation and prevalence in a hospital cohort.
    Bloquel B; Jeulin H; Burty C; Letranchant L; Rabaud C; Venard V
    J Med Virol; 2010 Feb; 82(2):206-12. PubMed ID: 20029819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of seven genotypes (A to E, G and H) of hepatitis B virus recovered from Japanese patients infected with human immunodeficiency virus type 1.
    Shibayama T; Masuda G; Ajisawa A; Hiruma K; Tsuda F; Nishizawa T; Takahashi M; Okamoto H
    J Med Virol; 2005 May; 76(1):24-32. PubMed ID: 15779062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for acute liver enzyme abnormalities in HIV-hepatitis B virus-coinfected patients on antiretroviral therapy.
    Chauvel O; Lacombe K; Bonnard P; Lascoux-Combe C; Molina JM; Miailhes P; Girard PM; Carrat F
    Antivir Ther; 2007; 12(7):1115-26. PubMed ID: 18018770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombination of hepatitis B virus DNA in patients with HIV.
    Fallot G; Halgand B; Garnier E; Branger M; Gervais A; Roque-Afonso AM; Thiers V; Billaud E; Matheron S; Samuel D; Féray C
    Gut; 2012 Aug; 61(8):1197-208. PubMed ID: 22068164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preliminary evidence that azidothymidine does not affect hepatitis B virus replication in acquired immunodeficiency syndrome (AIDS) patients.
    Farraye FA; Mamish DM; Zeldis JB
    J Med Virol; 1989 Dec; 29(4):266-7. PubMed ID: 2621453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reconstitution of hepatitis B virus (HBV)-specific T cell responses with treatment of human immunodeficiency virus/HBV coinfection.
    Lascar RM; Gilson RJ; Lopes AR; Bertoletti A; Maini MK
    J Infect Dis; 2003 Dec; 188(12):1815-9. PubMed ID: 14673759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Virological and clinical aspects of HBV-HCV coinfection in HIV positive patients.
    Filippini P; Coppola N; Pisapia R; Martini S; Marrocco C; Di Martino F; Sagnelli C; Filippini A; Sagnelli E
    J Med Virol; 2007 Nov; 79(11):1679-85. PubMed ID: 17854026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication.
    Kim HJ; Yoo HS; Kim JC; Park CS; Choi MS; Kim M; Choi H; Min JS; Kim YS; Yoon SW; Ahn JK
    J Ethnopharmacol; 2009 Jul; 124(2):189-96. PubMed ID: 19409970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of chronic hepatitis B or C in HIV-infected patients with dual viral hepatitis.
    Soriano V; Barreiro P; Martín-Carbonero L; Castellares C; Ruiz-Sancho A; Labarga P; Ramos B; Gonzalez-Lahoz J
    J Infect Dis; 2007 Apr; 195(8):1181-3. PubMed ID: 17357055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The implications of antiviral drugs with activity against hepatitis B virus and HIV.
    Bottecchia M; Garcia-Samaniego J; Soriano V
    Curr Opin Infect Dis; 2007 Dec; 20(6):621-8. PubMed ID: 17975413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term therapy with tenofovir is effective for patients co-infected with human immunodeficiency virus and hepatitis B virus.
    de Vries-Sluijs TE; Reijnders JG; Hansen BE; Zaaijer HL; Prins JM; Pas SD; Schutten M; Hoepelman AI; Richter C; Mulder JW; de Man RA; Janssen HL; van der Ende ME
    Gastroenterology; 2010 Dec; 139(6):1934-41. PubMed ID: 20801123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversibility of cirrhosis in HIV/HBV coinfection.
    Mallet VO; Dhalluin-Venier V; Verkarre V; Correas JM; Chaix ML; Viard JP; Pol S
    Antivir Ther; 2007; 12(2):279-83. PubMed ID: 17503671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding the pathogenesis and management of hepatitis B/HIV and hepatitis B/hepatitis C virus coinfection.
    Cheruvu S; Marks K; Talal AH
    Clin Liver Dis; 2007 Nov; 11(4):917-43, ix-x. PubMed ID: 17981235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No effect of zidovudine on hepatitis B virus replication in homosexual men with symptomatic HIV-1 infection.
    Gilson RJ; Hawkins AE; Kelly GK; Gill SK; Weller IV
    AIDS; 1991 Feb; 5(2):217-20. PubMed ID: 2031694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. β-Thujaplicinol inhibits hepatitis B virus replication by blocking the viral ribonuclease H activity.
    Hu Y; Cheng X; Cao F; Huang A; Tavis JE
    Antiviral Res; 2013 Sep; 99(3):221-9. PubMed ID: 23796982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Virology and clinical sequelae of drug-resistant HBV in HIV-HBV-coinfected patients on highly active antiretroviral therapy.
    Thio CL
    Antivir Ther; 2010; 15(3 Pt B):487-91. PubMed ID: 20516569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.